
Joaquin Duato
Joaquin Duato is the Chief Executive Officer of Johnson & Johnson, one of the world's largest pharmaceutical and medical device companies. He has been vocal about the potential impacts of US tariffs on the pharmaceutical industry, warning that such measures could lead to drug shortages and disrupt supply chains. Duato advocates for tax policy as a more effective means of boosting domestic manufacturing rather than tariffs. Under his leadership, J&J has committed to significant investments in US manufacturing.
Not in the pool (under ¢1).
Recent news mentions
Joaquin Duato is the chief executive of J&J who spoke with Taoiseach Micheál Martin about tariffs.
a new set of tariffs, and a company in Kinsale – The Irish TimesJoaquin Duato is the CEO of Johnson & Johnson and expects game-changing approvals in the second half of 2025.
Wall Street rattled as Donald Trump says he has discussed firing Jerome Powell, ASX set to riseHe introduced CEOs of major companies, including Johnson & Johnson's Joaquin Duato.
Trump tells business chiefs he needs 'little bit of time' as US economy shrinksJohnson & Johnson, under CEO Joaquin Duato, will invest $55 billion in new manufacturing and technology upgrades.
Trump touts trillion-dollar surge in U.S. investment — here’s who’s cashing inJoaquín Duato is the president and CEO of Johnson & Johnson, earning 24.3 million dollars.
Los CEO mejor pagados de Estados Unidos en 2024: los sueldos de más de 50 millones de dólares | EmpresasJoaquín Duato, president and CEO of Johnson & Johnson, earned 24.3 million dollars last year.
El español Javier Oliván ganó 25,5 millones de dólares en 2024 como director operativo de Meta | EconomíaJoaquin Duato, who leads one of the world’s biggest pharma and medical device companies, warned that pharmaceutical tariffs could create disruptions in the supply chain.
Johnson & Johnson warns pharma tariffs could cause drug shortages – The Irish Times

















































